nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.09.2014 | Article

Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system

verfasst von: M. Treviño, C. García-Riestra, P. Areses, X. García, D. Navarro, F. J. Suárez, I. A. López-Dequidt, O. Zaragoza, M. Cuenca-Estrella

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Trichosporon asahii has been recognized as an emerging opportunistic agent for invasive infections, mainly in immunocompromised patients. Urinary tract infections by this pathogen may also occur, especially in patients with urinary obstruction or those undergoing vesical catheterization and antibiotic treatment. Many outbreaks of Trichosporon spp. have been detected after urinary catheter manipulations. We report the molecular–epidemiological characterization of T. asahii in our institution using the DiversiLab system for the molecular strain typing and compare three different methods for susceptibility testing. Our results present T. asahii as an emergent pathogen in elderly patients with urinary drainage devices that can be adequately treated with triazoles, with voriconazole being the most active. Broth dilution and Vitek 2 had good concordance, while Etest showed more discrepancies. In addition, the DiversiLab system for clonal strain typing may be a useful tool for fast and accurate management of nosocomial outbreaks.

Chagas-Neto TC, Chaves GM, Colombo AL (2008) Update on the genus Trichosporon. Mycopathologia 166:121–132PubMedCrossRef

Colombo AL, Padovan AC, Chaves GM (2011) Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev 24:682–700PubMedCentralPubMedCrossRef

Kontoyannis DP, Torrs HA, Chagua M et al (2004) Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36:564–569CrossRef

Krzossok S, Birck R, Henke S, Hof H, van der Woude FJ, Braun C (2004) Trichosporon asahii infection of a dialysis PTFE arteriovenous graft. Clin Nephrol 62:66–68PubMedCrossRef

Falk R, Wolf DG, Shapiro M, Polacheck I (2003) Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J Clin Microbiol 41:911PubMedCentralPubMedCrossRef

Sun W, Su J, Xu S, Yan D (2012) Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol 61:1750–1757PubMedCrossRef

Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E et al (2005) Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 49:4026–4034PubMedCentralPubMedCrossRef

Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14:398–405CrossRef

Healy M, Huong J, Bittner T et al (2005) Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol 43:199–207PubMedCentralPubMedCrossRef

10.

Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T (2002) Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 40:1826–1830PubMedCentralPubMedCrossRef

11.

Rodriguez-Tudela JL, Gómez-López A, Alastruey-Izquierdo A, Mellado E, Bernal-Martínez L, Cuenca-Estrella M (2007) Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 58:435–440PubMedCrossRef

12.

Rodrigues Gda S, de Faria RR, Guazzelli LS, Oliveira Fde M, Severo LC (2006) Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases. Rev Iberoam Micol 23:85–89PubMedCrossRef

13.

Li H, Lu Q, Wan Z, Zhang J (2010) In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents 35:550–552PubMedCrossRef

14.

Hazirolan G, Cantón E, Sahin S, Arikan-Akdagli S (2013) Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii. Antimicrob Agents Chemother 57:4841–4847PubMedCentralPubMedCrossRef

15.

Mekha N, Sugita T, Ikeda R et al (2010) Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 169:67–70PubMedCrossRef

16.

Tsai MS, Yang YL, Wang AH et al (2012) Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Mycopathologia 174:121–130PubMedCrossRef

17.

Ruan SY, Chien JY, Hsueh PR (2009) Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis 49:e11–e17PubMedCrossRef

18.

Silva V, Zepeda G (2003) First Chilean report of nosocomial urinary tract infection due to Trichosporon asahii in 2 patients. Rev Med Chil 131:461–463PubMed

19.

Walsh TJ, Melcher GP, Rinaldi MG et al (1990) Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 28:1616–1622PubMedCentralPubMed

20.

Cejudo MA, Gallego AG, Lacasa EC et al (2010) Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method. Med Mycol 48:710–719PubMedCrossRef

21.

Lemes RM, Lyon JP, Moreira LM, de Resende MA (2010) Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies. Braz J Microbiol 41:310–315PubMedCentralPubMedCrossRef

22.

Healy M, Reece K, Walton D et al (2005) Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol 43:5278–5280PubMedCentralPubMedCrossRef

23.

Pounder JI, Williams S, Hansen D, Healy M, Reece K, Woods GL (2005) Repetitive-sequence-PCR-based DNA fingerprinting using the Diversilab system for identification of commonly encountered dermatophytes. J Clin Microbiol 43:2141–2147PubMedCentralPubMedCrossRef

24.

Cangelosi GA, Freeman RJ, Lewis KN et al (2004) Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains. J Clin Microbiol 42:2685–2693PubMedCentralPubMedCrossRef

25.

Healy M, Reece K, Walton D, Huong J, Shah K, Kontoyiannis DP (2004) Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol 42:4016–4024PubMedCentralPubMedCrossRef

26.

Kontoyiannis DP, Lionakis MS, Lewis RE et al (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case–control observational study of 27 recent cases. J Infect Dis 191:1350–1360PubMedCrossRef

27.

Redkar RJ, Dubé MP, McCleskey FK, Rinaldi MG, Del Vecchio VG (1996) DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR. J Clin Microbiol 34:1677–1681PubMedCentralPubMed

Titel: Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system
verfasst von: M. Treviño
C. García-Riestra
P. Areses
X. García
D. Navarro
F. J. Suárez
I. A. López-Dequidt
O. Zaragoza
M. Cuenca-Estrella
Publikationsdatum: 01.09.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2014
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-014-2099-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2014

Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia

Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays

Increased risk of pulmonary tuberculosis among patients with appendectomy in Taiwan

Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies

Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin